These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
3. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Uyeki TM Pediatr Infect Dis J; 2003 Feb; 22(2):164-77. PubMed ID: 12586981 [TBL] [Abstract][Full Text] [Related]
4. Updated treatment for influenza A and B. Montalto NJ; Gum KD; Ashley JV Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232 [TBL] [Abstract][Full Text] [Related]
5. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE; J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262 [TBL] [Abstract][Full Text] [Related]
6. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza]. de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128 [TBL] [Abstract][Full Text] [Related]
7. Influenza: evolving strategies in treatment and prevention. Lynch JP; Walsh EE Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors. Höffken G; Gillissen A Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354 [TBL] [Abstract][Full Text] [Related]
12. Oseltamivir: new preparation. An antiviral agent with little impact on influenza. Prescrire Int; 2003 Jun; 12(65):85-8. PubMed ID: 12825569 [TBL] [Abstract][Full Text] [Related]
13. ACIP releases guidelines on the prevention and control of influenza. Advisory Committee on Immunization Practices. Preboth M; Am Fam Physician; 2001 Oct; 64(7):1270, 1272-5. PubMed ID: 11601808 [No Abstract] [Full Text] [Related]
14. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice. Vogel GE Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352 [TBL] [Abstract][Full Text] [Related]
15. Use of antiviral agents and other measures in an influenza pandemic. Groeneveld K; van der Noordaa J Neth J Med; 2005 Oct; 63(9):339-43. PubMed ID: 16244380 [TBL] [Abstract][Full Text] [Related]
16. What is the best antiviral agent for influenza infection? Fagan HB; Moeller AH Am Fam Physician; 2004 Oct; 70(7):1331-2. PubMed ID: 15508545 [No Abstract] [Full Text] [Related]
17. [Oral neuraminidase inhibitor and an early warning system. New weapons against influenza]. Lange W; Vogel GE MMW Fortschr Med; 2003 Jan; 145(3-4):36-7. PubMed ID: 12619232 [No Abstract] [Full Text] [Related]
18. Neuraminidase inhibitors for treatment of influenza. Ebell MH Am Fam Physician; 2004 Jun; 69(12):2824. PubMed ID: 15222647 [No Abstract] [Full Text] [Related]